Comparison of Recombinant Cumulase with Bovine Derived Hyaluronidase for Oocyte Denudation before ICSI in Sibling Oocytes
DOI:
https://doi.org/10.54536/ajmsi.v3i2.3662Keywords:
Bovine-Derived Hyaluronidase, Euploidy, Intracytoplasmic Sperm Injection (ICSI), Pregnancy Rate, Recombinant CumulaseAbstract
Assisted Reproductive Technology (ART) with Intra-cytoplasmic Sperm Injection (ICSI) commonly utilizes Bovine-Derived Hyaluronidase for oocyte denudation. The emergence of Recombinant Cumulase as an alternative merit an examination of its impact upon ICSI outcomes. We compared the effects of Recombinant Cumulase and Bovine-Derived Hyaluronidase on oocyte denudation during ICSI, investigating impact upon fertilization rates, blastulation rates, and euploidy rates, aiming to improve clinical practice and optimize ART for patient outcomes. This was a retrospective observational study involving 59 patients undergoing ICSI conducted at First IVF Fertility Centre, Abu Dhabi, United Arab Emirates. Oocytes from each patient were divided one group which employed Recombinant Cumulase, and the other group utilised Bovine-Derived hyaluronidase. Parameters such as age, number of oocytes retrieved, denudation outcomes, and euploidy rates were assessed to determine enzyme impact. Comparative analysis revealed no substantial difference in fertilisation rates or embryo development (blastocyst rate) between recombinant Cumulase and bovine-derived Hyaluronidase. However, the recombinant Cumulase group exhibited significantly higher (p<0.05) rates of normal euploid embryos (Recombinant Cumulase-48.5%; Bovine Derived Hyaluronidase- 38.0%), indicating a potential advantage. However, the results are from small cohort and need to be validated with large sample size. Selecting enzymes for ART procedures is challenging. Although no significant differences were observed in fertilisation rates, the Recombinant Cumulase group treated oocytes exhibited yielding higher normal euploid embryo rates. Not many studies have looked at the Euploidy rates with use of different enzymes for oocyte denudation. Further investigations are essential to refine best practices and advance patient outcomes in assisted reproduction.
Downloads
References
Al Khaldi, M. R., & Al-khaldi, M. (2023). A Systematic Review on Infertility in Men Due to Sperm DNA Damage: Causes Investigations, & Management. American Journal of Medical Science and Innovation, 2(2), 79–89. https://doi.org/10.54536/ajmsi.v2i2.1967.
Ashibe, S., Irisawa, K., Yokawa, K., & Nagao, Y. (2021). Mechanism of the adverse effect of hyaluronidase used for oocyte denudation on early development of bovine embryos. Zygote, 29(5), 337-341.
American Society for Reproductive Medicine- Denudation Q&A. https://www.asrm.org/practice-guidance/coding/coding-art-lab-procedures/oocytedenudation/
Cinnioglu, C., Kayali, R., Darvin,T., Akinwole, A., Milena, Jakubowska, M., & Harton, G. (2019). Aneuploidy Screening using Next Generation Sequencing. Methods Mol Biol. 2019, 1885, 85-102. https://doi.org/10.1007/978-1-4939-8889-1-6.
de Moura, B. R., Gurgel, M. C., Machado, S. P., Marques, P. A., Rolim, J. R., de Lima, M. C., & Salgueiro, L. L. (2017). Low concentration of hyaluronidase for oocyte denudation can improve fertilization rates and embryo quality. JBRA Assisted Reproduction, 21(1), 27.
Evison, M., Pretty, C., Taylor, E., & Franklin, C. (2009). Human recombinant hyaluronidase (Cumulase®) improves intracytoplasmic sperm injection survival and fertilization rates. Reproductive biomedicine online, 18(6), 811-814.
Furuhashi, K., Goto, S., Hashimoto, H., Matsumoto, Y., Kokeguchi, S., & Shiotani, M. (2010). Comparison of bovine-and recombinant human-derived hyaluronidase in ICSI patients. Journal of Mammalian Ova Research, 27(2), 61-64.
Gardner, D & Balaban, B. (2016). Assessment of human embryo development using morphological criteria in an era of time-lapse, algorithms and ‘OMICS’: is looking good still important? Molecular Human Reproduction, 2016(22). https://doi.org/10.1093/molehr/gaw057.
Gardner, D. K., Lane, M., Stevens, J., Schlenker, T., & Schoolcraft, W, B. (2000). Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertility and Steriity. 2000 Jun, 73(6), 1155-8. https://doi.org/10.1016/s0015-0282(00)00518-5.
Harper, J., Coonen, E., De Rycke, M., Fiorentino, F., Geraedts, J., Goossens, V., Harton, G., Moutou, C., Budak,T., Renwick,P., SenGupta,S., Traeger-Synodinos, J., & Vesela,K. (2010) What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium steering committee. Human Reproduction, 25(4), 821–823, 2010.
Ishizuka, Y., Takeo, T., Nakao, S., Yoshimoto, H., Hirose, Y., Sakai, Y., ... & Nakagata, N. (2014). Prolonged exposure to hyaluronidase decreases the fertilization and development rates of fresh and cryopreserved mouse oocytes. Journal of Reproduction and Development, 60(6), 454-459.
Jung, H. (2020). Hyaluronidase: An overview of its properties, applications, and side effects. Archives of plastic surgery, 47(04), 297-300.
Lee, J. H., Yoo, M., Lee, S. M., Park, S. J., Kil, T. Y., & Kim, M. K. (2021). Toxicity of the recombinant human hyaluronidase ALT-BC4 on embryonic development. Journal of Animal Science and Technology, 63(2), 272.
Mukurunge, T., Rapitse, S., & Bhila, T. (2023). Reproductive Health and the Women of Lesotho: The Challenges. Journal of Innovative Research, 1(2), 1–6. https://doi.org/10.54536/jir.v1i2.1631.
Parinaud, J., Vieitez, G., Milhet, P., & Richoilley, G. (1998). Use of a plant enzyme preparation (Coronase) instead of hyaluronidase for cumulus cell removal before intracytoplasmic sperm injection. Human reproduction, 13(7), 1933-1935.
Rubino, P., Viganò, P., Luddi, A., & Piomboni, P. (2016). The ICSI procedure from past to future: a systematic review of the more controversial aspects. Human reproduction update, 22(2), 194-227.
Taylor, T. H., Elliott, T., Colturato, L. F., Straub, R. J., Mitchell-Leef, D., & Nagy, Z. P. (2006). Comparison of bovine-and recombinant human-derived hyaluronidase with regard to fertilization rates and embryo morphology in a sibling oocyte model: a prospective, blinded, randomized study. Fertility and sterility, 85(5), 1544-1546.
Tjahyadi, D., Susiarno, H., Chandra, B. A., Permadi, W., Djuwantono, T., & Wiweko, B. (2022). The effect of oocyte denudation time and intracytoplasmic sperm injection time on embryo quality at assisted reproductive technology clinic–A cross-sectional study. Annals of Medicine and Surgery, 80, 104234.
Tsampras, N., Kollmann, M., & Craciunas, L. (2022). Recombinant versus bovine hyaluronidase for oocyte denudation before intracytoplasmic sperm injection: a systematic review and meta-analysis. Journal of Obstetrics and Gynaecology, 42(2), 301-305.
Van de Velde, H., Nagy, Z. P., Joris, H., De Vos, A., & Van Steirteghem, A. C. (1997). Effects of different hyaluronidase concentrations and mechanical procedures for cumulus cell removal on the outcome of intracytoplasmic sperm injection. Human reproduction, 12(10), 2246-2250.
VOS, D. (2008). Randomized sibling-oocyte study using recombinant human hyaluronidase versus bovine-derived Sigma hyaluronidase in ICSI patients. Human. Reproduction., 23, 1815-1819.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 M. Fakih, B. R. Daoud, K. Khalil, M. Fawaz, J. Kashir, M. A. Akhtar
This work is licensed under a Creative Commons Attribution 4.0 International License.
